Rett syndrome is a neurodevelopmental disorder affecting 1 in 10,000-15,000 females worldwide. Apparently normal at birth, girls with Rett syndrome undergo developmental regression and acquire a neurologic and behavioral profile which has been used to define diagnostic criteria for the disorder. Although Rett syndrome generally occurs sporadically rare familial recurrences indicate a genetic basis for the disorder. Several features are consistent with an X-linked dominant locus including: (1) the exclusive occurrence of the classic phenotype in females; (2) the identification of severely affected males in Rett syndrome kindreds; (3) mother to daughter transmission; and (4) non-random X-chromosome inactivation patterns in nonmanifesting obligate carrier females. Exclusion mapping data from these rare families with recurrent Rett syndrome localize the gene to the distal long am of the X chromosome (Xq27.3-Xqter). The focus of this proposal is the identification of the causative gene using combined molecular and cytogenetic approaches. Based on their previous work and the milieu and resources of the new Human Genetics department at UCLA, they are in an excellent position to perform these studies. The investigations will test three primary hypotheses using combined molecular and cytogenetic approaches.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
1R01HD037874-01
Application #
2884431
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Oster-Granite, Mary Lou
Project Start
2000-01-01
Project End
2004-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
1
Fiscal Year
2000
Total Cost
$209,906
Indirect Cost
Name
University of California Los Angeles
Department
Genetics
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Weintraub, William S; Mandel, Leonid; Weiss, Sandra A (2013) Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations. Pharmacoeconomics 31:959-70
Hogart, Amber; Wu, David; LaSalle, Janine M et al. (2010) The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis 38:181-91
O'Connor, R D; Zayzafoon, M; Farach-Carson, M C et al. (2009) Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone 45:346-56
Kumar, Asmita; Kamboj, Sachin; Malone, Barbara M et al. (2008) Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci 121:1128-37
Dragich, Joanna M; Kim, Yong-Hwan; Arnold, Arthur P et al. (2007) Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol 501:526-42
Schanen, N Carolyn (2006) Epigenetics of autism spectrum disorders. Hum Mol Genet 15 Spec No 2:R138-50
Chang, Jay H; Vuppalanchi, Deepika; van Niekerk, Erna et al. (2006) PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control cAMP response element-dependent transcription in response to nerve growth factor and cAMP. J Neurochem 99:1517-30
Baron, Colin A; Tepper, Clifford G; Liu, Stephenie Y et al. (2006) Genomic and functional profiling of duplicated chromosome 15 cell lines reveal regulatory alterations in UBE3A-associated ubiquitin-proteasome pathway processes. Hum Mol Genet 15:853-69
Twiss, Jeffery L; Chang, Jay H; Schanen, N Carolyn (2006) Pathophysiological mechanisms for actions of the neurotrophins. Brain Pathol 16:320-32
Ham, Andrea L; Kumar, Asmita; Deeter, Rose et al. (2005) Does genotype predict phenotype in Rett syndrome? J Child Neurol 20:768-78

Showing the most recent 10 out of 18 publications